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Immune lymphoid ceils have been recently shown to be capable of inflicting 
cytotoxic damage on various normal and neoplastic target ceils in tissue cul- 
ture  in different immunological  systems  (1-7).  The  effect was attributed  to 
"cell-bound" antibodies, as contrasted to humoral antibodies, since it did not 
require complement (2, 5, 7), which is necessary for the cytotoxic action of the 
latter. The possibility that immune lymphoid cells secrete diffusible substances 
responsible for target cell destruction was made unlikely since their effect was 
abolished by separating  the  two cell  types by cell  impermeable  fakers  in  a 
diffusion chamber (8).  Cell-free supernatants  of cultivated immune lymphoid 
cells did not show any cytotoxic effects on sensitive target cells (8). 
Different authors have pointed out that close cellular  contact between im- 
mune  lymphoid  cells  and  target  cells  always  precedes  demonstrable  cyto- 
toxicity.  Recent  reports  (9,  10)  go one  step  further  in  demonstrating  that 
agglutination of normal,  non-immune lymphoid cells onto target cells in vitro 
brought about by inactivated heterologous antiserum (10), or by phytohemag- 
glutinln (9, 10) leads to target cell destruction. The normal cells had no effect 
unless artificially aggregated on the targets. Target cell death was not due to 
aggregation as such, however, since isologous lymphoid cells had no effect (10). 
This type of cytotoxicity could not be explained  by a conventional immuno- 
logical  reaction since lymphoid cells of F1 hybrid origin killed parental target 
cells after contact had been established by agglutination,  in spite of the fact 
that hybrid cells are not believed to be genetically competent to react against 
parental target ceils (10). These results suggested that contact between anti- 
genlcally and/or structurally different ceils may result in target cell destruction. 
It has been previously shown that  the growth-inhibiting  effect of immune 
lymphoid cells on tumor cells in vivo can be partially or completely suppressed 
by the exposure in vivo to humoral antibodies directed against the neoplastic 
target  ceils  (11,  12). The present study represents a  similar  investigation by 
the use of in vitro systems, with the specific aim of obtaining some knowledge 
about the kinetics of "cell-bound" and humoral immunity and their possible 
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interaction in the destruction  of tumor target ceils. The use of in vitro systems 
is motivated by the fact that  the investigation can be performed in the  com- 
plete absence of complement activity, thus avoiding complications of humoral 
immunity which might interfere with the action of the cells. 
Materials and Methods 
M/ce.--Tumors and  tissues  were sampled  from inbred  mice of the  strains  C57BL/KI 
(H-2 b H-gb), C3H/KI (//-2  ~ H-gk), A.CA/KI (H-2 ///-Z/), h/Sn  (H-Z  a H-2a), and  A.SW/KI 
(~-e. ~-z'). 
Tumors.--FHA is a  sarcoma induced by the implantation of cellophane film into a  C3H 
mouse  and  has  been  described  previously  (13).  MC57S  is  a  methylcholanthrene-induced 
sarcoma of the C57BL strain  (14),  and  MACD a  methylcholanthrene-induced  sarcoma of 
(A X  A.CA)F1 hybrid origin (11). 
Antlserum.--An  A.CA anti-C57BL serum was used.  It was collected by puncturing  the 
retr0orbital sinus of A.CA mice, preimmunized with 6 to 10 weekly injections of living C57BL 
spleen and  lymph node ceils.  The last  challenge was given 6 days prior to bleeding.  The 
hemagglutinating titers varied between ~'~58 and ~'~04s- All sera were sterilized  by ultrafil- 
tration through 0.45/x millipore filters prior to use. 
Immune Lymphoid  Cells.--A distinction will be made between hyperimmtme and immune 
lymphoid ceils. The former were obtained from animals immunized 6 to 10 times as described 
above.  Spleen and  lymph nodes were removed aseptically and  pressed  through a  60 mesh 
stainless steel screen into balanced salt solution (BSS), containing 100 IU of penicillin and 100 
/~g streptomycin/ml.  "Immune" lymphoid  cells were taken  exclusively from  the regional 
lymph nodes of mice treated with a single subcutaneous injection of allogeneic lymphoid cells 
7 to 10 days earlier. Control lymphoid cells were collected in the same way from tmimmunized 
animals. 
Complement.--Fresh  guinea pig serum was used as a source of complement. It was sterilized 
by u!trafiltration, and used in a final concentration of 10 per cent. In some cases the comple- 
ment was inactivated by heating at 56°C for 30 minutes. 
Tissue Culture.--'rumor  cell suspensions were prepared for explantation by treating finely 
minced tumor  tissue with 0.25  per cent trypsin  solution for  1 hour at room temperature. 
Subsequently the ceils were washed and 106 trypan blue-unstained cells suspended in 1 mi of 
lactalbumen in Earle's solution supplemented with 10 per cent calf serum (or, in later experi- 
ments, with the same concentration of fetal calf serum), were added to each culture tube. 
The medium contained mycostatin (30 IU/ml) and penicillin (100 IU/ml). After 24 hours it 
was replaced with Parker 199 medium supplemented with 10 per cent serum as above. 
In experiments designed to study the cytotoxic effect of immune and non-immune lymphoid 
ceils,  the tubes were exposed  to  the lymphoid cells immediately after the first change  of 
medium; i.e., 24 hours after explantation. As a  rule, 10  ~ lymphoid cells were added to each 
tube and incubated for 48 hours. Analogous experiments were performed with humoral iso- 
antibodies by adding 0.1 ml undiluted serum to each tube. In experiments designed to study 
the interaction of serum antibodies and  immune lymphoid  cells,  the serum was added  30 
minutes prior to the admixture of the cells. 
After 48 hours' incubation the tubes were treated with 1 ml 0.25 per cent trypsin solution 
for 30 to 60 minutes as 37°C, interrupted  by repeated shaking.  They were centrifuged and 
part  of the supernatant  removed. The number  of trypan  blue-unstained  tumor cells was 
counted and the volume of the supernatant was measured. Due to the pronounced size differ- 
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RESULTS 
Cytotoxic Effects of Immune Lymphoid Cells on Target Tumor Cells in Vitro. 
--As a first step, the in vitro cytotoxicity  of immune lymphoid ceils was studied 
with the purpose of working out favorable experimental conditions. The target 
tumor ceils were derived from sarcomas  MC57S  of C57BL  origin,  FHA of 
C3H origin, and MACD of (A X  A.CA)F1 hybrid origin. 
The best cytotoxic effect was obtained with regional lymph node ceils de- 
rived from an animal pretreated with a  single immunizing injection 7 to 10 
days earlier.  Between  25.6 and 96.2 per cent target tumor cells were killed 
with maximum effect obtained after 48 hours' incubation. Some cytotoxicity 
was  apparent  after  24  hours.  Complement  was  not  required  for  cytotoxic 
action,  in  contrast  to  cytotoxic reactions  involving  humoral isoantibodies. 
Control cultures were either left untreated or were incubated with non-immune 
lymphoid ceils derived from the same H-2 incompatible  strain as the immune 
cells. In comparison with untreated controls,  there was a detectable cytotox- 
ieity in the cultures exposed to non-immune allogeneic lymph node cells, but 
this effect was always much weaker  than the action of the immunized cells 
(Table I). 
As shown previously the cytotoxic action of the non-immune ceils could be 
attributed to the action of heterologous  antibodies  capable  of reacting with 
the mouse tissues and present in the calf serum used for supplementation of 
the medium. This effect could be reproduced  and amplified experimentally by 
treating the target cells with heat-inactivated rabbit anti-mouse tissue serum 
prior to the addition of normal allogeneic lymphoid ceils (10). 
In contrast to the strong effect of the lymph node cells 8 to 10 days after 
primary immunization, spleen cells of the same animals showed only a weak 
ability to kill the tumor ceils (Table II). Furthermore, a mixture of spleen and 
lymph node  ceils of animals repeatedly immunized against  the  target  cell 
genotype did not kill the target cells. The regional  lymph node cells from 
hyperimmune mice were highly cytotoxic, however, while the spleen cells had 
a much lower effect (Table II). 
Thus the source of the lymphoid ceils did seem to affect the outcome of the 
experiments,  whereas their primary or hyperimmune state did not. It seemed 
conceivable  that  the  inability of the  spleen  ceils to  kill H-2  incompatible 
target ceils was due to their production of humoral isoantibodies in vitro, since 
the spleen is known to be involved in humoral antibody production to a major 
extent (15). If so, the humoral antibodies in the medium would combine with 
the  antigenic determinants of  the  target  cells, thus  protecting  them from 
destruction by the  immunologically  competent lymph node  cells. Such  an 
"efferent inhibition" of transplantation immunity by humoral antibodies has 
been demonstrated repeatedly in various in vivo systems (11). TABLE I 
Cytotoxic  Effect of Normal and lsoimmune* Lymph Node Cells on Sarcoma Cells 
in Tissue Culture in the Prescence of 10 Per Cent Heat-Inactivated 
Calf Serum 
Exp. 
No. 
Target 
tumors:l: 
MC575¶ 
MC575 
MC575 
MC575 
MC575 
MC575 
MC575 
MC575 
MACD** 
Lymph node cdls from 
A.CA Anti-C57BL 
A.CA Untreated 
A.CA Anti-C57BL 
A.CA Untreated 
A.CA Anti-CS7BL 
A.CA Untreated 
A.CA Anti-C57BL 
A.CA Untreated 
A.CA Anti-C57BL 
A.CA Untreated 
A.CA Anti-C57BL 
A.CA Untreated 
A.CA Anti-C57BL 
A.CA Untreated 
A.SW Anti-C57BL 
A.SW Untreated 
A.CA Anti-A 
A.CA Untreated 
No. of 
lymph 
node cells 
X  l0 s 
I0.0 
I0.0 
10.0 
10.0 
7.5 
7.5 
5.0 
5.0 
5.0 
5.0 
5.0 
5.0 
20.0 
10.0 
5.0 
20.0 
10.0 
10.0 
10.0 
10.0 
No. of living 
tumor cells§ 
X l0  t -4- s~ 
34 -4- 3.3  41.0 
83 -4- 11.9  100.0 
91  -4- 16.8  41.5 
219 4- 35.8  100.0 
140 -4- 21.9  50.3 
279 4- 35.8  100.0 
21  q- 5.7  13.6 
154 4- 35.0  100.0 
126 -4- 30.3  39.5 
319 4- 60.5  100.0 
119 4- 6.7  50.4 
236 -4- 25.3  100.0 
98 -4- 25.1  30.7 
ll0 4- 18.1  34.5 
276 -4- 46.5  86.5 
319 -4- 56.6  100.0 
7 :k 3.4  3.8 
I06 4- 13.0  58.3 
183 -4- 14.0  100.0 
35 -4- 4.6  27.4 
109 4- 11.5  85.1 
128 4- 22.4  100.0 
Per cent living 
ceils and cyto- 
toxic indexll as 
compared to 
controls 
(0.59) 
(0.59) 
(o.so) 
(o.86) 
(o.61) 
(o.so) 
(0.69) 
(0.66) 
(0.14) 
(0.96) 
(0.42) 
(o.73) 
(o.15) 
* Isoimmtme lymph node cells were taken 7 to 10 days after the first subcutaneous inocu- 
lation of living spleen and lymph node cells of the tumor genotype. 
10  s living trypsinized tumor cells were added to each culture tube 24  hours  prior  to 
the experiment. The medium consisted of lactalbumin in Earle's solution for the explantation 
and was thereafter replaced with Parker's Medium 199, both supplemented with 10 per cent 
calf serum. 
§ 43 hours after the addition of the lymph node cells the tubes were treated with 1 ml 
0.25 per cent trypsin solution for 30 to 60 minutes at 37°C and the number of trypan blue- 
unstained tumor cells counted in a haemocytometer. The figures given are the mean of 5 tubes 
or more. 
[I The cytotoxic index is defined as the difference between the percentage living cells in 
the control and experimental group divided by the former figure. 
¶  Sarcoma  MC57S  is  of  C57BL  origin. 
** Sarcoma  MACD  is  of  (A  X  A.CA)  F, hybrid  origin. 
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Exp. 
No. 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
Target 
tumors:I: 
MC57S 
MACD 
MC57S 
MC57S 
MC57S 
MC57S 
MC57S 
MC57S 
MC57S 
MC57S 
MC57S 
No. of  No. of living  lymph  Lymph node cells from  node ceils  tumor  cells§ 
X  10 s  X  10  3 -4- s~ 
A.CA Anti-C57BL  5.0  156 4- 32.9 
A.CA Untreated  5.0  396 4- 16.7 
--  --  469 4- 51.4 
A.SW  Anti-A  6.0  170 4- 26.2 
A.SW Untreated  6.0  342  4- 37.2 
--  439 ±  67.2 
A.CA Anti-C57BL  8.5  102 4- 19.0 
A.CA Untreated  8.5  222 4- 27.8 
--  247 4- 39.4 
A.CA Anti-C57BL  10.0  183 4- 37.5 
A.CA Untreated  10.0  382 4- 34.3 
--  --  428 4- 28.7 
A.CA Anti-C57BL  10.0  237 4- 17.2 
A.CA Untreated  10.0  475 4- 48.1 
--  533 4- 75.1 
A.CA Anti-C57BL  10.0  156 4- 32.3 
A.CA Untreated  10.0  312 4- 50.1 
--  --  320 4- 39.4 
A.CA Anti-C57BL  20.0  162 4- 18.7 
"  "  10.0  185 4- 17.4 
"  "  5.0  193 4- 26.9 
A.CA Untreated  20.0  261  4- 11.0 
"  "  10.0  266 4- 38.5 
"  "  5.0  246 4- 22.8 
--  --  318  4-  15.9 
A.CA Anti-C57BL  10.0  176 4-4- 23.5 
A.CA Untreated  10.0  265 4-4- 24.0 
--  --  314 4- 20.7 
A.CA Anti-C57BL  10.0  258 -4- 25.3 
A.CA Untreated  10.0  406 -4- 24.2 
--  --  414 4- 39.4 
A.CA Anti-C57BL  7.0  271  4- 41.7 
A.CA Untreated  7.0  379 4- 24.0 
--  --  387 -4- 35.0 
A.CA Anti-C57BL  10.0  343 4- 29.4 
A.CA Untreated  10.0  451 4- 8.5 
--  --  462 4- 37.3 
Per cent living 
cells and cyto- 
toxic indexl[ as 
compared to 
controls 
33.2 (0.67) 
8o.5 (o. 20) 
i00.0 
38.8 (0.61) 
78.0 (0.22) 
100.0 
41.4 (0.59) 
89.9 (0.10) 
100.0 
42.8 (0.57) 
89.2  (0.11) 
100.0 
44.5 (o.56) 
89.1  (0.11) 
100.0 
48.8  (0.51) 
97.5 (0.03) 
100.0 
50.9 (0.49) 
58.2  (0.42) 
60.7 (0.39) 
82.1  (0.16) 
83.6 (o.16) 
77.9 (0.22) 
100.0 
56.1  (o.44) 
84.5  (0.16) 
100.0 
62.4 (0.38) 
98.0 (0.02) 
100.0 
70.0 (0.30) 
98.5 (0.02) 
100.0 
74.4 (0.26) 
98.o (o.o2) 
100.0 
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Comparisons  between  the  Cytotoxlc  Effect  of Humeral  Antibodies  and  Cell- 
Mediated Reactions in Vitro.--Pronounced  differences  were  found  between 
the kinetics of the cytotoxie effect on MC57S ceils of humoral antibodies and 
cell-mediated reactions. Immune lymph node cells had no demonstrable effect 
TABLE II 
In Vitro Cytotox~ity of Immune and Hyp~immune Spleen and Lymph Node Cdls 
on Allogeneic Target Tumor Cells 
Exp. 
No. 
Target 
tumor 
FHA* 
MC57S§ 
MC575 
MC575 
MC575 
A.CA lymphoid cells derived from 
Hyperimmune~ spleen and lymph node  343 
Normal spleen and lymph node  377 
Hyperimmune spleen and lymph node  396 
Normal spleen and lymph node  390 
No. of living 
tumor cells 
X  lO  s :I: sE 
4- 33.0 
4- 24.7 
4- 18.9 
4- 29.9 
Hyperimmune lymph node 
"  spleen 
Normal lymph node 
"  spleen 
Immune lymph nodel[ 
"  spleen 
Normal lymph node 
"  spleen 
Immune lymph node 
"  spleen 
Normal lymph node 
"  spleen 
156 ±  32.9 
291 4- 13.5 
396 4- 16.7 
392 4- 3212 
469 4- 51.4 
346 4- 39.0 
442 4- 23.8 
488 4- 59.5 
527 -b 49.5 
516 4- 42.5 
38-4- 7.7 
106 4- 16.5 
102 4- 16.2 
152 4- 16.3 
144 4- 18.0 
Per cent 
living tumor 
cells as 
compared 
to controls 
91.0 
100 
>I00 
100 
33.3 
62.0 
84.4 
83.6 
100 
67.1 
85.7 
94.6 
>100 
100 
26.4 
73.6 
70.8 
>100 
100 
* FHA is a  sarcoma indigenous to the  C3H strain. 
Hyperimmune  cells were derived from A.CA mice repeatedly  immunized against the 
corresponding tumor genotype. 
§ MC57S is a sarcoma indigenous to the C57BL strain. 
I[ Immune  cells were derived from A.CA mice injected once 7 to 10 days before explanta- 
tion. 
prior to  24 hours of incubation; the number of killed target  cells reached a 
maximum after  48  hours  and did not increase subsequently. The  cytotoxic 
sensitivity to humoral isoantibodies of tumor cells in suspension varies with 
the  cell  type.  The MC575  tumor has  an  "intermediate" sensitivity to  H-2 ~NA  ~6LLER  17 
isoantibodies in the presence of complement, as judged by the cytotoxic assay 
by Gorer and O'Gorman (16). The titer was ~o  to ~o  in repeated experiments 
and  the cytotoxic index varied between 0.33  and 0.76.  Cytotoxic tests with 
humoral  antibodies  and  MC57S  target  ceils  were  also  performed  in  tissue 
culture. When a N0 diluted A.CA anti-CS7BL serum was added to the tumor 
ceils in culture in the absence of complement, there was no detectable effect 
on the number of ceils. If complement was added  (diluted  ~0),  there was a 
marked decrease in  the  number of living cells  as  early as  2  hours,  and  the 
effect increased during the subsequent 2 hours.  Mter 24 or 48 hours' incuba- 
tion the cell number was not significantly different from the controls, however. 
TABLE III 
Effect of Complement on the Cytotoxic Action of Immune Lymphoid Cells 
on MC57S Tumor Cdls in Tissue Culture 
Exp. 
No.  Type of A. CA lymphoid  cells 
Hyperimmune spleen and lymph node 
Normal spleen and lymph node 
Immune lymph node 
Normal lymph node 
Complement* 
Active 
Inactive 
Active 
Inactive 
Active 
Inactive 
Active 
Inactive 
No. of living 
tumor cells 
.X 10  8 -4-  SE 
408 :=1:25.8 
442 4- 35.0 
592 4- 22.9 
550 4- 44.8 
95 4- 16.9 
144 4- 8.2 
298 4- 31.5 
246 4- 21.6 
Per cent 
living 
tumor 
cells as 
compared 
to controls 
68.9 
74.7 
100 
92.9 
31.9 
48.3 
100 
82.6 
* Complement was inactivated by heat at 56°C for 30 minutes. 
This might be re]ated to an exhaustion of complement and subsequent growth 
of surviving ceils, or to a  decrease of cell number in the cultures  exposed to 
normal serum during the first days of incubation, leading to a diminution and 
eventual disappearance of the difference between the two groups. Complement 
alone did not have any significant effect on the cells.  Thus, the humoral and 
the  cell-mediated  reaction  culminated  at  very different  times.  It  has  been 
shown previously that immune lymphoid ceils do not require complement for 
their cytotoxic action, in contrast to humoral antibodies. This was confirmed 
in the present study and is illustrated in Table III. 
Inhibition  of  the  Cytotoxic  Effect  of Immune  Lympkoid  Cells  by  Humoral 
Antibodies.--Since  immune  lymphoid  cells  and  humoral  antibodies  show 
marked differences with regard to their requirements for cytotoxic efficiency, 
an investigation  on  the  possible interaction  between  these  types of immune 18  ANTAGONISTIC EFFECTS  OF  1:tuMORAL  ISOANTIBODIES 
mechanisms appears of interest. As stated above, in vivo investigations of this 
problem have demonstrated synergistic and antagonistic interactions as well, 
depending on the experimental conditions (11, 12). The present in vitro system 
allows the study of such interactions in the absence of complement, in order 
to avoid the complications resulting from cytotoxicity of humoral antibodies. 
TABLE IV 
Antagonistic  Effects  of Humoral Isocmtibodies on the in Vitro Cytotoxicity  of Immune 
Lymph Node Cells on MC57S Target  Tumor Cells 
Exp. No.  Type of A. CA 
lymph node cells 
Immune 
Normal 
~* 
Immune 
Normal 
Immune 
44 
Normal 
z  : 
Immune 
• Normal 
Immune 
c~ 
Normal 
Type of serum* 
Immune 
Normal 
Immune 
Normal 
Per cent living 
No. of living tumor  tumor cells as 
ceils X I0  :i: SE  compared to 
controls 
228 4- 39.4 
156 4- 31.2 
239 4- 46.6 
312 4- 51.0 
Immune 
Normal 
Immune 
Normal 
Immune 
Normal 
Immune 
Normal 
Immune 
Normal 
Immune 
Normal 
4- 
4- 
± 
4- 
4- 
± 
4- 
± 
140 
255 
361 
298 
265 
135 
338 
279 
34 4- 
83 4- 
79 4- 
79 ± 
80 4- 
57 ± 
72 4- 
73 ± 
22.5 
37.1 
45.0 
72.0 
39,3 
11.9, 
33.8 
22,3: 
3.3 
11.9 
7.4 
7.2 
9.6 
5.1 
7.8 
6.8 
73.1 
50.0 
76.6 
100 
50.2 
91.4 
>100 
>100 
i  95.0 
48:4 
> 100 
>100 
46.6 
>  100: 
> 100 
>100 
> 100 
78.1 
98.6 
100 
* The immune serum employed was an A.CA anti-C57BL serum with a hemagglutinating 
titer of 1/256 to 1/2048. Normal serum was from untreated A.CA mice. 
Humoral antibodies (A.CA auti-C57BL)  taken from repeatedly immunized 
mice were added to the cultures of MC57S  sarcoma cells in a  final dilution of 
~0.  One  hour  later  107  lymphoid cells from  A.CA  mice immunized  8  days 
previously were added to the tumor cells. Various controls were run in parallel. 
Thus, the MC57S target cells were exposed to humoral antibodies, to immune 
lymph node cells, to normal lymph node cells, to normal serum, and to various 
combinations  of  these.  All experiments  were  performed  With  tissue  culture 
medium  supplemented  with  fetal  calf  serum  instead  of  adultserum,  since ERNA  MOLLER  19 
previous experiments demonstrated that normal~  non-immune lymphoid  cells 
brought about a  certain target cell destruction when calf serum was added to 
the medium, whereas fetal calf serum did not cause significant cytotoxicity 
(10). 
In the presence of normal mouse serum, immune lymphoid cells  exerted a 
marked cytotoxic effect on the  tumor cells  as found before.  Normal lymph 
node cells had no effect, neither in the presence nor in the absence of isoanti- 
serum (Table IV). The addition of immune serum to the cultures prior to the 
immune lymph node cells inhibited the cytotoxic effect partially or completely 
in repeat experiments. 
The  results  clearly demonstrate  that  humoral antibodies  can  antagonize 
the cytotoxic effect of immune lymphoid cells. This is in line with the previ- 
ously reported  finding that humoral antibodies can counteract the  growth- 
inhibiting action of "cell-bound" antibodies and thereby cause immunological 
enhancement. Asia consequence, the low cytotoxic efficiency of immune spleen 
cells may be attributed to their high production of humoral antibodies, react- 
ing the antigenic determinants and blocking th~ attachment site for immune 
lymphoid cells. 
DISCUSSION 
Much interest has been centered on the mechanism by which humoral and 
cell-bound antibodies kill target cells in the course of the homograft reaction 
(see  references  17-19).  Humoral antibodies are  cytotoxic for some types of 
nucleated tissue cells  (usually of lymphoid origin) in vitro  in the presence of 
complement. Suspended cells are killed very rapidly (15 to 30 minutes). Other 
cells,  such as certain tumor cells, are more resistant but can nevertheless be 
killed under appropriate circumstances (13, 20). The critical variable has been 
identified as  the concentration of antigenic determinants  (13,  21,  22).  The 
characteristics  of the  cell-bound immunity are  quite  different, as  shown in 
this and other studies. The effect takes longer time (24 to 48 hours), and does 
not require  complement. Maximum cytotoxic activity of immune lymphoid 
cells is reached 7 to 10 days after immunization and decreases thereafter, in 
contrast to the production of humoral antibodies (at least those of the 7S type, 
which are mostly responsible for in vitro  cytotoxicity) (23).  Serum titers in- 
crease during the first 2 to 3 weeks after immunization and reach high levels 
only after hyperimmunization. Lymph node cells  show a  much higher cyto- 
toxic activity in vitro than spleen cells. Probably, humoral antibodies synthe- 
sized in the spleen interfere with the cytotoxic effect. 
A  suggestion was put forward recently to explain the mechanism of cell- 
bound immunity (10).  It was shown that normal allogeneic but not lsologous 
lymphoid cells were fully competent to kill tumor target cells in tissue culture 
subsequent  to  their aggregation around  the  target  cells,  which was  accom- 20  ANTAGONISTIC  EFFECTS  OF  HUMORAL  ISOANTIBODIES 
plished  by  treatment  with  heterologous  antibodies  or  phytohemagglutinin. 
Cytotoxicity could not be explained by conventional immunological reactions 
(such as antibody production), since F1 hybrid lymphoid cells killed parental 
target cells, in spite of the fact that the hybrid cells are not genetically com- 
petent to react immunologically against the target cells. It was also found that 
lymphoid cells pretreated  with  1500 r  were effective in  this system (24).  It 
seemed more likely that close contact between antigenically and/or structurally 
incompatible cells  results in target cell  destruction. However, in  vitro  cyto- 
toxicity also occurred when the lymphoid cells did not contain foreign isoanti- 
gens (F1 targets and parental lymphoid cells) (24). Two alternative explanations 
may account for these findings: (a) target cell destruction is the consequence of 
close contact between cells carrying foreign histocompatibility antigens; or (b) 
cell death occurs after aggregation with structurally incompatible ceils which 
need not necessarily be antigenically incompatible. According to the first hy- 
pothesis, destruction of parental target cells subsequent to contact with semi- 
isologous hybrid ceils would be a  direct effect on the targets, whereas in the 
reverse situation cytotoxicity must be explained by an indirect effect; only the 
parental lymphoid cells can be killed in this mixture, but their death would sec- 
ondarily lead to cytotoxic effects on the aggregating cellular partner. The sec- 
ond alternative implies that structural differences which are not necessarily re- 
lated to antigenicity are responsible for cytotoxicity. An F1 target cell aggre- 
gated to a parental lymphoid cell is not confronted with foreign isoantigens, but 
probably with a structurally different cell surface. If this structural discrepancy 
is sufficient to cause cell  death, cytotoxicity would be a  direct effect on the 
target cells. 
It follows from the above results, that in vitro cytotoxicity  of immune lymph- 
oid cells on various target cells is caused by their capacity to aggregate specifi- 
cally with  antigenically incompatible  target  ceils,  most likely because  they 
possess a specific receptor reacting with the antigens of the target cells. Cyto- 
toxicity would be the consequence of the contact with the cells  and not be 
caused by specific immune reactions. 
According to  this  scheme  the  cytotoxic effect of immune lymphoid cells 
would depend on the presence of specific receptors facilitating attachment to 
the  target ceil  and  the death of these cells  be complement independent, in 
contrast to antibody-induced cytotoxicity. 
The  present  finding  that  pretreatment  of  the  target  cells  with  humoral 
antibodies inhibited the  cytotoxic effect of immune lymphoid cells  directed 
against the same isoantigens as the antibodies, is in agreement with the hy- 
pothesis above:  the antibodies react with the antigenic determinants of the 
target cells, thereby blocking the site of attachment of the lymphoid cells. As 
a  result, no close contact can be established between two incompatible cells 
and  cytotoxicity cannot  occur.  Thus,  it  seems  likely  that  cell-bound  and E~NA M6LIm~  21 
humoral antibodies have the same immunological specificity in this system, in 
contrast  to  other  immunological systems  (25),  where  cell-bound  antibodies 
have been shown to be directed against a larger part of the antigen molecule 
compared to serum antibodies. If this were the case in the present  system, 
inhibition by humoral antibodies would probably not occur, unless factors not 
related to immunological specificity such as steric hindrance, were responsible. 
It is not possible as yet to exclude steric factors in the  present test system, 
however. 
Humoral  antibody-induced  inhibition  of  cell-bound  as  well  as  humoral 
immunity has  been  demonstrated  in  a  variety  of  immunological  systems 
(for reference see 26). The antibody effect has been demonstrated to occur at 
different levels and to have different effects, but is in all cases dependent upon 
the  reaction  with  the  antigen.  Humoral  antibodies  may  interact  with  the 
antigen at an "afferent" level, thereby inhibiting the initiation of the immune 
response, or at an "efferent" level as in the present case leading to protection 
of the target cells from destruction by immunologically competent cells.  Both 
mechanisms are  responsible for the phenomenon of immunological  enhance- 
ment. In addition, however,  7S  antibodies are  capable  of inhibiting cellular 
proliferation of 19S antibody-producing cells after antibody synthesis has been 
initiated  (23).  These manifold effects of humoral  antibodies all work in the 
same  direction and  tend to  inhibit new antibody production.  As  suggested 
elsewhere  (23),  humoral antibodies  may constitute  a  feed-back  mechanism 
regulating the extent of antibody synthesis and preventing the risks of hyper- 
immunization against an individual antigen. 
SUMMARY 
The ability of specifically immunized lymphoid cells to kill H-2 incompatible 
target tumor cells in tissue culture was shown to depend on the source of the 
lymphoid tissue  (spleen versus  lymph nodes). Marked cytotoxic effects were 
obtained with regional lymph node cells 7 to 10 days after primary immuniza- 
tion, whereas spleen cells from the same animals had little or no effect. Hyper- 
immunization did not decrease the cytotoxic efficiency of lymph node cells. 
Experiments were performed to  test the possibility that the weak effect of 
spleen cells is a  result of humoral antibody production, antagonizing the cell- 
bound immunity. 
Humoral antibodies were cytotoxic in  vitro in the presence of complement 
only. Their effect was manifested after 2 hours, whereas immune lymph node 
ceils did not require complement and cytotoxicity was not expressed until 24 
to 48  hours' incubation.  Tumor  cell  cultures  treated  with specific  humoral 
antibodies in  the absence  of complement became resistant to  the cytotoxic 
effect of subsequently added immune lymph node cells, while no such protec- 
tion was seen when normal serum was added. Thus, humoml antibodies led to 22  ANTAGONISTIC  EFFECTS  OF  HLr~ORAL  ISOANTIBODIES 
an "efferent" inhibition of cell-bound immunity in vitro,  in analogy with pre- 
vious results in vivo. 
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